{"gene":"P4HB","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2015,"finding":"A heterozygous missense mutation in P4HB (p.Tyr393Cys) located in the C-terminal disulfide isomerase domain of PDI sterically close to the enzymatic center impairs disulfide isomerase activity in vitro and causes Cole-Carpenter syndrome, a severe bone fragility disorder. Skin fibroblasts showed increased ER stress, but collagen type I secretion rate appeared normal.","method":"Whole-exome sequencing, in vitro disulfide isomerase activity assay, ER stress analysis in patient skin fibroblasts","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1/2 / Strong — in vitro enzymatic assay directly demonstrating loss of disulfide isomerase activity, combined with patient cell functional studies and identification of causative mutation; replicated in subsequent papers","pmids":["25683117"],"is_preprint":false},{"year":2019,"finding":"PDIA1/P4HB is required for efficient proinsulin disulfide maturation in pancreatic β cells. β cell-specific Pdia1 deletion in mice exacerbated glucose intolerance, increased the proinsulin/insulin ratio, caused accumulation of disulfide-linked high-molecular-weight proinsulin complexes, and produced ER vesiculation, mitochondrial swelling, and nuclear condensation.","method":"Conditional β cell-specific Pdia1 knockout mice, glucose tolerance tests, proinsulin/insulin ratio measurement in serum and islets, ultrastructural analysis, oxidative stress assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with multiple orthogonal phenotypic readouts (biochemical, ultrastructural, metabolic) in vivo","pmids":["31184304"],"is_preprint":false},{"year":2024,"finding":"PDIA1 plays indispensable roles in APOB folding and MTTP synthesis/function to support VLDL assembly and secretion in hepatocytes. Hepatocyte-specific Pdia1 deletion inhibited MTTP expression at the translational level (not mRNA or protein stability), dramatically reduced VLDL production, and caused severe hepatic steatosis and hypolipidemia. PDIA1 interacts with APOB in an MTTP-independent manner via its chaperone function. Catalytically inactivated PDIA1 mutant failed to rescue these phenotypes.","method":"Conditional hepatocyte-specific Pdia1 knockout mice, lipoprotein secretion assays, mRNA/protein stability analysis, Co-IP between PDIA1 and APOB, catalytic mutant complementation","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo conditional knockout with mechanistic dissection using catalytic mutants and direct protein interaction assays","pmids":["38211723"],"is_preprint":false},{"year":2022,"finding":"P4HB is a substrate for UFMylation at three lysine residues (mono-UFMylation). UFMylation deficiency promotes P4HB protein degradation via the ubiquitin-proteasome pathway, leading to mitochondrial function damage, oxidative stress, and ER stress in HepG2 cells.","method":"Stable cell line with UFMylation-defective P4HB, proteasome inhibitor rescue experiments, mitochondrial function assays, ROS measurement, ER stress markers","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — identification of a novel PTM with functional consequence demonstrated in a cell line, single lab with multiple assays","pmids":["35753586"],"is_preprint":false},{"year":2024,"finding":"P4HB is lactylated at lysine K311; aloe emodin inhibits binding of lactate to the K311 site of P4HB. P4HB lactylation was identified as a novel post-translational modification relevant to radiation-induced heart disease.","method":"4D label-free lactylation omics, cross differential omics, molecular docking, identification of K311 as the lactylation site","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — proteomics-based PTM identification with site-specific mapping, single lab","pmids":["39494721"],"is_preprint":false},{"year":2013,"finding":"P4HB inhibition (by RNAi knockdown or bacitracin) sensitizes temozolomide-resistant glioblastoma cells to TMZ through the PERK arm of the endoplasmic reticulum stress response. P4HB overexpression conferred TMZ resistance in sensitive cells.","method":"RNAi knockdown, pharmacological inhibition (bacitracin), in vitro and in vivo xenograft models, ER stress pathway analysis (PERK arm)","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function with defined pathway placement (PERK-ER stress), validated in vivo, single lab","pmids":["23444257"],"is_preprint":false},{"year":1991,"finding":"P4HB encodes a multifunctional polypeptide that serves as the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer (which catalyzes 4-hydroxyproline formation in collagens) and is identical to the enzyme protein disulfide isomerase. The gene was mapped to chromosome 17q25.","method":"In situ hybridization, Southern blot analysis of chromosome-mediated gene transfer transfectant panel","journal":"Cytogenetics and cell genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — dual functional identity established biochemically and replicated across multiple subsequent studies; chromosomal mapping confirmed","pmids":["1647289"],"is_preprint":false},{"year":2017,"finding":"P4HB (PDI) in its tetrameric form catalyzes hydroxylation of proline residues within X-Pro-Gly repeats in the procollagen helical domain. The recurrent mutation p.Tyr393Cys in the C-terminal reactive centre interferes with disulfide isomerase function of PDI. Fibroblast analysis suggests P4HB perturbation disrupts ECM organization and assembly rather than collagen type I secretion per se.","method":"Collagen analysis in cultured fibroblasts, electron microscopy, exome sequencing, clinical phenotyping","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fibroblast functional assays with structural analysis, single lab, confirms prior finding","pmids":["29263160"],"is_preprint":false},{"year":2020,"finding":"PDIA1 acts as master organizer of NOX1/NOX4 balance in vascular smooth muscle cells (VSMCs). Early PDIA1 overexpression increased NOX1 expression, H2O2 levels, and spontaneous VSMC migration; sustained overexpression also increased NOX4 and switched VSMC phenotype to differentiation. PDIA1 knockdown decreased nuclear myocardin and increased PCNA expression. Both NOX1 and H2O2 were necessary for PDIA1-induced VSMC differentiation. In vivo, TgPDIA1 carotids showed decreased NOX1 and enhanced NOX4/calponin, indicating overdifferentiation.","method":"Inducible PDIA1 overexpression in VSMCs, siRNA knockdown, transgenic PDIA1-overexpressing mice (TgPDIA1), rabbit overdistension injury model, NOX1/NOX4 expression and activity assays, nuclear myocardin imaging","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (overexpression, knockdown, transgenic mice, in vivo injury model) from single lab with multiple functional readouts","pmids":["33227407"],"is_preprint":false},{"year":2022,"finding":"PDIA1 (P4HB) is a target protein of Disulfide bond Disrupting Agents (DDAs). Affinity purification with biotinylated DDAs identified PDIA1 as a DDA-binding protein. DDA treatment of breast cancer cells disrupts PDIA1 mixed disulfide bonds with client proteins, contributing to DR4/DR5 oligomerization and cancer cell death.","method":"Affinity purification with biotinylated-DDAs, shRNA knockdown, mixed disulfide bond analysis","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — affinity purification identifies direct binding, functional consequence demonstrated, single lab","pmids":["35247515"],"is_preprint":false},{"year":2021,"finding":"P4HB is secreted in extracellular vesicles from esophageal squamous cell carcinoma cells and promotes apoptosis of skeletal muscle cells by activating the ubiquitin-dependent proteolytic pathway and regulating the stability of PHGDH and subsequent antiapoptotic protein Bcl-2, contributing to cancer cachexia.","method":"ESCC-induced cachexia mouse model, EV isolation, P4HB inhibitor (CCF642) treatment, apoptosis assays, PHGDH/Bcl-2/caspase-3 pathway analysis","journal":"Journal of extracellular vesicles","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo functional studies with defined pathway (PHGDH/Bcl-2/caspase-3), single lab","pmids":["33732415"],"is_preprint":false},{"year":2020,"finding":"SAL (salidroside) inhibits skin inflammation and melanogenesis by targeting P4HB (confirmed by molecular docking and Biacore binding). P4HB mediates ubiquitination-dependent degradation of IRF1; inhibition of P4HB by SAL prevents IRF1 ubiquitin degradation. IRF1 and USF1 form a transcription complex that regulates tyrosinase (TYR) mRNA expression.","method":"Molecular docking, Biacore surface plasmon resonance, Co-IP, pull-down, proximity ligation assay, luciferase reporter assay, immunofluorescence, Western blot","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding confirmed by SPR, protein interaction validated by Co-IP/pull-down, mechanistic pathway established, single lab","pmids":["33042273"],"is_preprint":false},{"year":2023,"finding":"The ER stress sensor IRE1 regulates collagen secretion through transcriptional induction of P4HB/PDIA1, which is required for collagen maturation. Genetic ablation of IRE1 reduced P4HB expression, caused collagen retention at the ER and altered secretion, and diminished collagen deposition in liver fibrosis models. P4HB overexpression rescued collagen secretion in IRE1-deficient cells.","method":"IRE1 genetic ablation, carbon tetrachloride and high-fat diet liver fibrosis models, proteomic and transcriptomic profiling, P4HB overexpression rescue, collagen retention/secretion assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic ablation with rescue experiment, multiple in vivo models, preprint not yet peer-reviewed","pmids":["37205565"],"is_preprint":true},{"year":2017,"finding":"P4HB promotes malignant glioma phenotypes (proliferation, invasion, migration, angiogenesis) via the MAPK signaling pathway. Genetic and pharmacologic inhibition of P4HB suppressed MAPK expression and downstream angiogenic/invasive targets.","method":"P4HB overexpression and knockdown, in vitro proliferation/invasion/migration/angiogenesis assays, in vivo tumor growth, MAPK pathway analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function with defined pathway placement (MAPK), validated in vivo, single lab","pmids":["29069756"],"is_preprint":false},{"year":2024,"finding":"P4HB interacts with PRMT1 (confirmed by immunoprecipitation), and this interaction mediates P4HB's regulation of the TGFβ/SMAD3 signaling pathway in high glucose-induced renal tubular epithelial cells. Silencing P4HB inhibited EMT and fibrosis; overexpression of PRMT1 reversed P4HB knockdown effects on EMT, fibrosis, and TGFβ/SMAD3 signaling.","method":"siRNA knockdown, overexpression vectors, immunoprecipitation (P4HB-PRMT1 interaction), Western blot, immunofluorescence, ROS assay","journal":"BMC nephrology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP identifies interaction, epistasis by overexpression rescue supports pathway placement, single lab","pmids":["39251943"],"is_preprint":false},{"year":2021,"finding":"COL10A1 directly interacts with P4HB (confirmed by Co-IP). P4HB is required for COL10A1-mediated promotion of breast cancer cell proliferation, migration, and invasion, as P4HB knockdown abrogated the promoting effects of COL10A1 overexpression.","method":"Co-immunoprecipitation, siRNA knockdown of P4HB, CCK-8 proliferation assay, wound healing and transwell migration/invasion assays","journal":"Medical science monitor","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP with functional rescue, single lab, no deeper mechanistic characterization","pmids":["33637669"],"is_preprint":false},{"year":2017,"finding":"P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition (EMT). GRP78 overexpression antagonized the oncogenic effects of P4HB overexpression in HCC cells.","method":"P4HB overexpression and silencing, in vitro growth/migration/invasion/EMT assays, in vivo tumor xenografts, GRP78 modulation","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss-of-function with pathway placement (GRP78/EMT), in vivo validation, single lab","pmids":["28052026"],"is_preprint":false},{"year":2018,"finding":"P4HB knockdown in HT29 colon cancer cells induces apoptosis through accumulation of reactive oxygen species (ROS) and subsequent inactivation of STAT3 signaling. Inhibiting ROS accumulation abrogated the increased apoptosis, and decreased ROS effectively antagonized P4HB knockdown effects on STAT3 inactivation.","method":"siRNA knockdown, ROS measurement, STAT3 phosphorylation assay, apoptosis assay, ROS inhibitor rescue","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via chemical rescue establishes ROS→STAT3 as mechanistic pathway downstream of P4HB, single lab","pmids":["30431122"],"is_preprint":false},{"year":2023,"finding":"ARID1A depletion in lung cancer cells augments P4HB expression and secretion; secreted P4HB induces activation of lung fibroblasts through the β-catenin signaling pathway. P4HB-activated fibroblasts promote proliferation, invasion, and chemoresistance of lung cancer cells. Antibody-based P4HB neutralization hampered tumor growth and increased cisplatin efficacy in PDX models.","method":"siRNA knockdown of ARID1A, conditioned media experiments, antibody neutralization, β-catenin pathway analysis, PDX mouse models","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (β-catenin) established with in vivo PDX validation and neutralization rescue, single lab","pmids":["38100120"],"is_preprint":false},{"year":2021,"finding":"PDIA1 is upregulated in NOD mouse islets and pancreatic sections from humans with autoantibody positivity or T1D. PDIA1 plasma levels are increased in pre-diabetic NOD mice and in children with recent-onset T1D, suggesting PDIA1 as a biomarker of β cell stress.","method":"Data independent acquisition-mass spectrometry on longitudinally collected islets from NOD mice, immunohistochemistry of human pancreatic sections, ELISA for plasma PDIA1","journal":"EBioMedicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proteomics/IHC-based correlation without direct mechanistic experiment on P4HB function; primarily biomarker identification","pmids":["36463755"],"is_preprint":false}],"current_model":"P4HB/PDIA1 encodes the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer and is identical to protein disulfide isomerase (PDI); it resides in the ER where it catalyzes disulfide bond formation and isomerization essential for folding of collagen (via the prolyl 4-hydroxylase complex), proinsulin, apolipoprotein B (APOB), and MTTP, thereby controlling VLDL secretion and insulin production; it is subject to UFMylation (stabilizing it) and lactylation (at K311), and its activity is regulated by the ER stress sensor IRE1 which drives P4HB transcription to support collagen secretion; loss-of-function mutations (e.g., p.Tyr393Cys) impair disulfide isomerase activity and cause Cole-Carpenter syndrome/osteogenesis imperfecta; in vascular smooth muscle, PDIA1 orchestrates the NOX1/NOX4 balance to control phenotype switching; in cancer contexts, P4HB promotes malignant phenotypes via MAPK signaling, STAT3/ROS pathways, and by regulating fibroblast activation through β-catenin, and its inhibition restores chemosensitivity through the PERK/ER stress pathway."},"narrative":{"mechanistic_narrative":"P4HB encodes a multifunctional ER-resident polypeptide that is simultaneously the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer and the enzyme protein disulfide isomerase (PDI/PDIA1), thereby coupling collagen prolyl hydroxylation with oxidative protein folding [PMID:1647289]. Through its disulfide isomerase activity it governs the maturation of multiple secretory clients: it is required for proinsulin disulfide maturation in pancreatic beta cells, where its loss elevates the proinsulin/insulin ratio and produces disulfide-linked high-molecular-weight proinsulin aggregates [PMID:31184304], and it supports hepatic VLDL assembly by chaperoning APOB and enabling MTTP synthesis, with catalytic activity being essential for these functions [PMID:38211723]. Its expression is wired to the unfolded protein response: the ER stress sensor IRE1 transcriptionally induces P4HB to drive collagen maturation and secretion [PMID:37205565]. A heterozygous p.Tyr393Cys mutation in the C-terminal disulfide isomerase domain abolishes isomerase activity and causes Cole-Carpenter syndrome, a severe bone fragility/osteogenesis imperfecta disorder, acting through disrupted ECM organization rather than a defect in collagen type I secretion per se [PMID:25683117, PMID:29263160]. P4HB protein abundance and activity are tuned by post-translational modification, including stabilizing UFMylation whose loss triggers proteasomal degradation, oxidative and ER stress [PMID:35753586]. Beyond folding, P4HB orchestrates redox signaling—balancing NOX1/NOX4 to control vascular smooth muscle phenotype switching [PMID:33227407]—and in cancer it promotes malignant phenotypes through MAPK signaling [PMID:29069756], ROS/STAT3 signaling [PMID:30431122], GRP78 downregulation with EMT [PMID:28052026], and secreted P4HB that activates fibroblasts via beta-catenin to drive chemoresistance [PMID:38100120].","teleology":[{"year":1991,"claim":"Established the dual molecular identity of P4HB, showing one gene product serves both as the prolyl 4-hydroxylase beta-subunit and as protein disulfide isomerase, defining its place in collagen biosynthesis and oxidative folding.","evidence":"In situ hybridization and Southern blot of chromosome-transfer transfectants mapping the gene and establishing dual function","pmids":["1647289"],"confidence":"High","gaps":["Did not resolve how the two catalytic roles are partitioned in vivo","No structural model of the alpha2beta2 tetramer provided"]},{"year":2013,"claim":"Linked P4HB activity to chemoresistance, showing its inhibition sensitizes resistant tumor cells via the PERK arm of the ER stress response.","evidence":"RNAi and bacitracin inhibition with PERK pathway analysis in temozolomide-resistant glioblastoma, validated in xenografts","pmids":["23444257"],"confidence":"Medium","gaps":["Bacitracin is not P4HB-specific","Direct catalytic dependence not dissected"]},{"year":2015,"claim":"Demonstrated that a specific P4HB mutation causes human disease by impairing disulfide isomerase activity, tying enzymatic loss-of-function to a Mendelian bone fragility syndrome.","evidence":"Whole-exome sequencing, in vitro isomerase assay, and ER stress analysis of patient fibroblasts for p.Tyr393Cys","pmids":["25683117"],"confidence":"High","gaps":["Normal collagen I secretion left the bone phenotype mechanism unresolved","Heterozygous mechanism (dominant-negative vs haploinsufficiency) not defined"]},{"year":2017,"claim":"Refined the disease mechanism, indicating P4HB perturbation disrupts ECM organization and assembly rather than collagen type I secretion itself.","evidence":"Collagen and electron microscopy analysis of patient fibroblasts with exome sequencing","pmids":["29263160"],"confidence":"Medium","gaps":["Molecular basis of ECM disorganization not identified","Single-lab fibroblast study"]},{"year":2017,"claim":"Placed P4HB's oncogenic activity downstream of defined signaling, implicating MAPK and GRP78/EMT axes in tumor promotion.","evidence":"Gain/loss-of-function with MAPK pathway analysis in glioma and GRP78 modulation in HCC, both with in vivo validation","pmids":["29069756","28052026"],"confidence":"Medium","gaps":["How catalytic isomerase function connects to MAPK/GRP78 not established","Direct substrates in these pathways unknown"]},{"year":2018,"claim":"Defined a ROS-STAT3 axis downstream of P4HB, showing its knockdown drives apoptosis through ROS accumulation and STAT3 inactivation.","evidence":"siRNA knockdown with ROS measurement, STAT3 phosphorylation, and ROS-inhibitor rescue in colon cancer cells","pmids":["30431122"],"confidence":"Medium","gaps":["Source of ROS upon P4HB loss not identified","Single-lab in vitro study"]},{"year":2019,"claim":"Established a physiological catalytic role in proinsulin folding, showing P4HB is required for proinsulin disulfide maturation and beta cell function.","evidence":"Beta cell-specific Pdia1 knockout mice with glucose tolerance, proinsulin/insulin ratio, and ultrastructural analysis","pmids":["31184304"],"confidence":"High","gaps":["Whether PDIA1 acts directly on proinsulin disulfides or via partner chaperones not resolved","Specific disulfide bonds catalyzed not mapped"]},{"year":2020,"claim":"Revealed a redox-signaling role beyond folding, with PDIA1 acting as master organizer of the NOX1/NOX4 balance to control vascular smooth muscle phenotype switching.","evidence":"Inducible overexpression, siRNA, transgenic mice, and in vivo injury model with NOX activity and myocardin readouts","pmids":["33227407"],"confidence":"High","gaps":["Molecular mechanism by which PDIA1 sets NOX1/NOX4 balance not defined","Direct interaction with NOX enzymes not shown"]},{"year":2020,"claim":"Identified P4HB as a regulator of IRF1 stability, controlling melanogenesis and skin inflammation through ubiquitin-dependent degradation of IRF1.","evidence":"SPR binding, Co-IP, pull-down, PLA, and luciferase assays with the inhibitor salidroside","pmids":["33042273"],"confidence":"Medium","gaps":["How P4HB mechanistically promotes IRF1 ubiquitination unclear","Single-lab study"]},{"year":2021,"claim":"Extended P4HB function to extracellular and cancer-cachexia contexts, showing secreted/EV P4HB and direct partners drive muscle apoptosis and tumor aggression.","evidence":"EV isolation with PHGDH/Bcl-2 pathway analysis in ESCC cachexia, Co-IP with COL10A1 in breast cancer, and biomarker proteomics in T1D islets","pmids":["33732415","33637669","36463755"],"confidence":"Medium","gaps":["How an ER-resident protein is secreted and functions extracellularly not mechanistically resolved","COL10A1 interaction rests on a single Co-IP with functional rescue","T1D data are correlative biomarker findings without direct mechanism"]},{"year":2022,"claim":"Showed P4HB stability is post-translationally controlled by UFMylation, linking this modification to redox and ER homeostasis.","evidence":"UFMylation-defective P4HB cell line with proteasome rescue, mitochondrial, ROS, and ER stress assays in HepG2","pmids":["35753586"],"confidence":"Medium","gaps":["UFMylated lysine residues not individually mapped to function","Ligase/machinery directing P4HB UFMylation not identified"]},{"year":2022,"claim":"Identified P4HB as the molecular target of disulfide-bond-disrupting agents, connecting its mixed-disulfide client interactions to death-receptor oligomerization in cancer.","evidence":"Affinity purification with biotinylated DDAs, shRNA knockdown, and mixed disulfide bond analysis in breast cancer cells","pmids":["35247515"],"confidence":"Medium","gaps":["Full client repertoire forming mixed disulfides not enumerated","Single-lab characterization"]},{"year":2023,"claim":"Wired P4HB expression to the unfolded protein response, showing IRE1 transcriptionally induces P4HB to enable collagen maturation and secretion.","evidence":"IRE1 genetic ablation with P4HB overexpression rescue in liver fibrosis models (preprint)","pmids":["37205565"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Transcription factor link between IRE1 and the P4HB promoter not detailed"]},{"year":2023,"claim":"Defined P4HB as a secreted driver of stromal activation, showing ARID1A loss elevates secreted P4HB that activates fibroblasts via beta-catenin to promote chemoresistance.","evidence":"ARID1A knockdown, conditioned media, antibody neutralization, and PDX models in lung cancer","pmids":["38100120"],"confidence":"Medium","gaps":["Fibroblast receptor for secreted P4HB not identified","Single-lab study"]},{"year":2024,"claim":"Established an essential catalytic role in hepatic lipoprotein metabolism, with P4HB chaperoning APOB and enabling MTTP synthesis to support VLDL secretion.","evidence":"Hepatocyte-specific Pdia1 knockout, Co-IP with APOB, translational analysis of MTTP, and catalytic-mutant complementation","pmids":["38211723"],"confidence":"High","gaps":["Mechanism by which P4HB controls MTTP translation specifically unresolved","Chaperone vs catalytic contributions to APOB binding not fully separated"]},{"year":2024,"claim":"Added new layers of post-translational and interaction-based regulation, identifying K311 lactylation and a PRMT1 interaction modulating TGFbeta/SMAD3-driven fibrosis.","evidence":"4D lactylation proteomics and docking for K311; Co-IP and overexpression epistasis for PRMT1 in renal tubular cells","pmids":["39494721","39251943"],"confidence":"Medium","gaps":["Functional consequence of K311 lactylation on enzymatic activity not measured","PRMT1 interaction rests on single-lab Co-IP and rescue"]},{"year":null,"claim":"How a single ER-resident isomerase coordinates its catalytic folding functions with its diverse cytosolic, extracellular, and signaling roles, and how its many post-translational modifications integrate to regulate these activities, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural/mechanistic model linking folding catalysis to signaling outputs","Secretion route for an ER-resident protein unexplained","Substrate-level specificity across tissues not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016853","term_label":"isomerase activity","supporting_discovery_ids":[0,1,2,6,7]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[2]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[6,7]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,2,12]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[10]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[10,18]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,2,6,12]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,12]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[6,7,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,13,17,18]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2]}],"complexes":["prolyl 4-hydroxylase alpha2beta2 tetramer"],"partners":["APOB","MTTP","PRMT1","COL10A1","IRF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P07237","full_name":"Protein disulfide-isomerase","aliases":["Cellular thyroid hormone-binding protein","Prolyl 4-hydroxylase subunit beta","p55"],"length_aa":508,"mass_kda":57.1,"function":"This multifunctional protein catalyzes the formation, breakage and rearrangement of disulfide bonds. At the cell surface, seems to act as a reductase that cleaves disulfide bonds of proteins attached to the cell. May therefore cause structural modifications of exofacial proteins. Inside the cell, seems to form/rearrange disulfide bonds of nascent proteins. At high concentrations and following phosphorylation by FAM20C, functions as a chaperone that inhibits aggregation of misfolded proteins (PubMed:32149426). At low concentrations, facilitates aggregation (anti-chaperone activity). May be involved with other chaperones in the structural modification of the TG precursor in hormone biogenesis. Also acts as a structural subunit of various enzymes such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein MTTP. Receptor for LGALS9; the interaction retains P4HB at the cell surface of Th2 T helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration (PubMed:21670307)","subcellular_location":"Endoplasmic reticulum; Endoplasmic reticulum lumen; Melanosome; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P07237/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P4HB","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CPSF6","stoichiometry":4.0},{"gene":"CANX","stoichiometry":0.2},{"gene":"MED9","stoichiometry":0.2},{"gene":"SAR1B","stoichiometry":0.2},{"gene":"SNRPF","stoichiometry":0.2},{"gene":"TOP1","stoichiometry":0.2},{"gene":"WASL","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/P4HB","total_profiled":1310},"omim":[{"mim_id":"618588","title":"PROTEIN DISULFIDE ISOMERASE-LIKE PROTEIN, TESTIS-EXPRESSED; PDILT","url":"https://www.omim.org/entry/618588"},{"mim_id":"616942","title":"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 5; PDIA5","url":"https://www.omim.org/entry/616942"},{"mim_id":"616175","title":"UBIQUITIN-CONJUGATING ENZYME E2 J1; UBE2J1","url":"https://www.omim.org/entry/616175"},{"mim_id":"611099","title":"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6; PDIA6","url":"https://www.omim.org/entry/611099"},{"mim_id":"610304","title":"DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2","url":"https://www.omim.org/entry/610304"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"pancreas","ntpm":2108.3}],"url":"https://www.proteinatlas.org/search/P4HB"},"hgnc":{"alias_symbol":["PDIA1","PROHB","DSI","GIT","PDI","PO4HB","P4Hbeta"],"prev_symbol":["PO4DB","ERBA2L"]},"alphafold":{"accession":"P07237","domains":[{"cath_id":"3.40.30.10","chopping":"21-132","consensus_level":"high","plddt":94.9461,"start":21,"end":132},{"cath_id":"3.40.30.10","chopping":"137-232","consensus_level":"high","plddt":95.7212,"start":137,"end":232},{"cath_id":"3.40.30.10","chopping":"237-347","consensus_level":"high","plddt":91.9501,"start":237,"end":347},{"cath_id":"3.40.30.10","chopping":"369-471","consensus_level":"high","plddt":93.4867,"start":369,"end":471}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P07237","model_url":"https://alphafold.ebi.ac.uk/files/AF-P07237-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P07237-F1-predicted_aligned_error_v6.png","plddt_mean":88.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P4HB","jax_strain_url":"https://www.jax.org/strain/search?query=P4HB"},"sequence":{"accession":"P07237","fasta_url":"https://rest.uniprot.org/uniprotkb/P07237.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P07237/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P07237"}},"corpus_meta":[{"pmid":"10622253","id":"PMC_10622253","title":"EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10622253","citation_count":1433,"is_preprint":false},{"pmid":"11559724","id":"PMC_11559724","title":"Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92.","date":"2001","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11559724","citation_count":328,"is_preprint":false},{"pmid":"16246726","id":"PMC_16246726","title":"The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16246726","citation_count":209,"is_preprint":false},{"pmid":"16598076","id":"PMC_16598076","title":"The multifunctional GIT family of proteins.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16598076","citation_count":196,"is_preprint":false},{"pmid":"15749028","id":"PMC_15749028","title":"IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells.","date":"2005","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/15749028","citation_count":135,"is_preprint":false},{"pmid":"10788515","id":"PMC_10788515","title":"GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10788515","citation_count":134,"is_preprint":false},{"pmid":"14597771","id":"PMC_14597771","title":"Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14597771","citation_count":133,"is_preprint":false},{"pmid":"8455607","id":"PMC_8455607","title":"Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8455607","citation_count":126,"is_preprint":false},{"pmid":"17928638","id":"PMC_17928638","title":"Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).","date":"2007","source":"Journal of physiology and pharmacology : an official journal of the Polish Physiological Society","url":"https://pubmed.ncbi.nlm.nih.gov/17928638","citation_count":122,"is_preprint":false},{"pmid":"14656986","id":"PMC_14656986","title":"Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT.","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14656986","citation_count":118,"is_preprint":false},{"pmid":"10896954","id":"PMC_10896954","title":"The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10896954","citation_count":118,"is_preprint":false},{"pmid":"12473661","id":"PMC_12473661","title":"The GIT family of proteins forms multimers and associates with the presynaptic cytomatrix protein Piccolo.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12473661","citation_count":115,"is_preprint":false},{"pmid":"27182061","id":"PMC_27182061","title":"Expanding functions of GIT Arf GTPase-activating proteins, PIX Rho guanine nucleotide exchange factors and GIT-PIX complexes.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27182061","citation_count":97,"is_preprint":false},{"pmid":"15212761","id":"PMC_15212761","title":"The GIT/PIX complex: an oligomeric assembly of GIT family ARF GTPase-activating proteins and PIX family Rac1/Cdc42 guanine nucleotide exchange factors.","date":"2004","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15212761","citation_count":94,"is_preprint":false},{"pmid":"25683117","id":"PMC_25683117","title":"Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25683117","citation_count":78,"is_preprint":false},{"pmid":"23444257","id":"PMC_23444257","title":"Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.","date":"2013","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23444257","citation_count":76,"is_preprint":false},{"pmid":"8227198","id":"PMC_8227198","title":"Six git genes encode a glucose-induced adenylate cyclase activation pathway in the fission yeast Schizosaccharomyces pombe.","date":"1993","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/8227198","citation_count":74,"is_preprint":false},{"pmid":"31184304","id":"PMC_31184304","title":"PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31184304","citation_count":73,"is_preprint":false},{"pmid":"18299239","id":"PMC_18299239","title":"The PIX-GIT complex: a G protein signaling cassette in control of cell shape.","date":"2008","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18299239","citation_count":71,"is_preprint":false},{"pmid":"29207176","id":"PMC_29207176","title":"P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29207176","citation_count":61,"is_preprint":false},{"pmid":"15010282","id":"PMC_15010282","title":"Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.","date":"2004","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/15010282","citation_count":60,"is_preprint":false},{"pmid":"11340068","id":"PMC_11340068","title":"BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11340068","citation_count":57,"is_preprint":false},{"pmid":"19023419","id":"PMC_19023419","title":"A RAC/CDC-42-independent GIT/PIX/PAK signaling pathway mediates cell migration in C. elegans.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19023419","citation_count":52,"is_preprint":false},{"pmid":"19136011","id":"PMC_19136011","title":"Structures of dimeric GIT1 and trimeric beta-PIX and implications for GIT-PIX complex assembly.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19136011","citation_count":50,"is_preprint":false},{"pmid":"24928894","id":"PMC_24928894","title":"RhoJ interacts with the GIT-PIX complex and regulates focal adhesion disassembly.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24928894","citation_count":50,"is_preprint":false},{"pmid":"32780989","id":"PMC_32780989","title":"GIT/PIX Condensates Are Modular and Ideal for Distinct Compartmentalized Cell Signaling.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32780989","citation_count":49,"is_preprint":false},{"pmid":"33732415","id":"PMC_33732415","title":"Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH/Bcl-2/caspase-3 pathway.","date":"2021","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/33732415","citation_count":49,"is_preprint":false},{"pmid":"12611588","id":"PMC_12611588","title":"Leucine-zipper-mediated homo- and hetero-dimerization of GIT family p95-ARF GTPase-activating protein, PIX-, paxillin-interacting proteins 1 and 2.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12611588","citation_count":47,"is_preprint":false},{"pmid":"31467922","id":"PMC_31467922","title":"P4HB, a Novel Hypoxia Target Gene Related to Gastric Cancer Invasion and Metastasis.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/31467922","citation_count":45,"is_preprint":false},{"pmid":"22944353","id":"PMC_22944353","title":"Demonstration of DSI-semen--A novel DNA methylation-based forensic semen identification assay.","date":"2012","source":"Forensic science international. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22944353","citation_count":45,"is_preprint":false},{"pmid":"33042273","id":"PMC_33042273","title":"Salidroside can target both P4HB-mediated inflammation and melanogenesis of the skin.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33042273","citation_count":44,"is_preprint":false},{"pmid":"28052026","id":"PMC_28052026","title":"P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28052026","citation_count":44,"is_preprint":false},{"pmid":"21926430","id":"PMC_21926430","title":"Sorting nexin 27 protein regulates trafficking of a p21-activated kinase (PAK) interacting exchange factor (β-Pix)-G protein-coupled receptor kinase interacting protein (GIT) complex via a PDZ domain interaction.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21926430","citation_count":40,"is_preprint":false},{"pmid":"35753586","id":"PMC_35753586","title":"P4HB UFMylation regulates mitochondrial function and oxidative stress.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35753586","citation_count":39,"is_preprint":false},{"pmid":"12649318","id":"PMC_12649318","title":"Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus.","date":"2003","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/12649318","citation_count":39,"is_preprint":false},{"pmid":"11350072","id":"PMC_11350072","title":"Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11350072","citation_count":38,"is_preprint":false},{"pmid":"24212182","id":"PMC_24212182","title":"From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.","date":"2013","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/24212182","citation_count":37,"is_preprint":false},{"pmid":"24882013","id":"PMC_24882013","title":"A presynaptic role for the cytomatrix protein GIT in synaptic vesicle recycling.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24882013","citation_count":36,"is_preprint":false},{"pmid":"33061438","id":"PMC_33061438","title":"Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33061438","citation_count":34,"is_preprint":false},{"pmid":"3029411","id":"PMC_3029411","title":"Dsi-1, a region with frequent proviral insertions in Moloney murine leukemia virus-induced rat thymomas.","date":"1987","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/3029411","citation_count":34,"is_preprint":false},{"pmid":"26637799","id":"PMC_26637799","title":"Presynaptic Deletion of GIT Proteins Results in Increased Synaptic Strength at a Mammalian Central Synapse.","date":"2015","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/26637799","citation_count":34,"is_preprint":false},{"pmid":"30431122","id":"PMC_30431122","title":"P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30431122","citation_count":33,"is_preprint":false},{"pmid":"32565952","id":"PMC_32565952","title":"P4HB modulates epithelial-mesenchymal transition and the β-catenin/Snail pathway influencing chemoresistance in liver cancer cells.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32565952","citation_count":32,"is_preprint":false},{"pmid":"371789","id":"PMC_371789","title":"Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.","date":"1979","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/371789","citation_count":32,"is_preprint":false},{"pmid":"36670347","id":"PMC_36670347","title":"Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis.","date":"2023","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36670347","citation_count":31,"is_preprint":false},{"pmid":"12367601","id":"PMC_12367601","title":"Presynaptic factors in the regulation of DSI expression in hippocampus.","date":"2002","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12367601","citation_count":31,"is_preprint":false},{"pmid":"33637669","id":"PMC_33637669","title":"Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.","date":"2021","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/33637669","citation_count":30,"is_preprint":false},{"pmid":"10561426","id":"PMC_10561426","title":"Evidence for endogenous excitatory amino acids as mediators in DSI of GABA(A)ergic transmission in hippocampal CA1.","date":"1999","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10561426","citation_count":30,"is_preprint":false},{"pmid":"32789019","id":"PMC_32789019","title":"Improving access to and effectiveness of mental health care for personality disorders: the guideline-informed treatment for personality disorders (GIT-PD) initiative in the Netherlands.","date":"2020","source":"Borderline personality disorder and emotion dysregulation","url":"https://pubmed.ncbi.nlm.nih.gov/32789019","citation_count":30,"is_preprint":false},{"pmid":"39494721","id":"PMC_39494721","title":"Aloe Emodin Alleviates Radiation-Induced Heart Disease via Blocking P4HB Lactylation and Mitigating Kynurenine Metabolic Disruption.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39494721","citation_count":27,"is_preprint":false},{"pmid":"25484297","id":"PMC_25484297","title":"The GTPase regulatory proteins Pix and Git control tissue growth via the Hippo pathway.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/25484297","citation_count":27,"is_preprint":false},{"pmid":"18559618","id":"PMC_18559618","title":"Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.","date":"2008","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18559618","citation_count":26,"is_preprint":false},{"pmid":"24325175","id":"PMC_24325175","title":"Poly(4-hydroxybutyrate) (P4HB) production in recombinant Escherichia coli: P4HB synthesis is uncoupled with cell growth.","date":"2013","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/24325175","citation_count":25,"is_preprint":false},{"pmid":"26188902","id":"PMC_26188902","title":"MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26188902","citation_count":25,"is_preprint":false},{"pmid":"20934403","id":"PMC_20934403","title":"TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20934403","citation_count":24,"is_preprint":false},{"pmid":"22747893","id":"PMC_22747893","title":"Secreted phospholipase A2-IIA-induced a phenotype of activated microglia in BV-2 cells requires epidermal growth factor receptor transactivation and proHB-EGF shedding.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22747893","citation_count":24,"is_preprint":false},{"pmid":"9893115","id":"PMC_9893115","title":"Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.","date":"1999","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9893115","citation_count":24,"is_preprint":false},{"pmid":"36140713","id":"PMC_36140713","title":"In-Silico Characterization of Estrogen Reactivating β-Glucuronidase Enzyme in GIT Associated Microbiota of Normal Human and Breast Cancer Patients.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36140713","citation_count":24,"is_preprint":false},{"pmid":"20154149","id":"PMC_20154149","title":"Cadherins and Pak1 control contact inhibition of proliferation by Pak1-betaPIX-GIT complex-dependent regulation of cell-matrix signaling.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20154149","citation_count":24,"is_preprint":false},{"pmid":"3313808","id":"PMC_3313808","title":"A great improvement of fusion efficiency in mouse B cell hybridoma production by use of the new culture medium, GIT.","date":"1987","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3313808","citation_count":23,"is_preprint":false},{"pmid":"29069756","id":"PMC_29069756","title":"Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29069756","citation_count":22,"is_preprint":false},{"pmid":"18460348","id":"PMC_18460348","title":"Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.","date":"2008","source":"Nitric oxide : biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18460348","citation_count":22,"is_preprint":false},{"pmid":"23451083","id":"PMC_23451083","title":"Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23451083","citation_count":20,"is_preprint":false},{"pmid":"30913006","id":"PMC_30913006","title":"NOVEL MUTATIONS IN THE WNT1, TMEM38B, P4HB, AND PLS3 GENES IN FOUR UNRELATED CHINESE FAMILIES WITH OSTEOGENESIS IMPERFECTA.","date":"2019","source":"Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists","url":"https://pubmed.ncbi.nlm.nih.gov/30913006","citation_count":20,"is_preprint":false},{"pmid":"29532415","id":"PMC_29532415","title":"In-vitro GIT Tolerance of Microencapsulated Bifidobacterium bifidum ATCC 35914 Using Polysaccharide-Protein Matrix.","date":"2019","source":"Probiotics and antimicrobial proteins","url":"https://pubmed.ncbi.nlm.nih.gov/29532415","citation_count":20,"is_preprint":false},{"pmid":"25176327","id":"PMC_25176327","title":"Improved productivity of poly (4-hydroxybutyrate) (P4HB) in recombinant Escherichia coli using glycerol as the growth substrate with fed-batch culture.","date":"2014","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/25176327","citation_count":20,"is_preprint":false},{"pmid":"35247515","id":"PMC_35247515","title":"Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/35247515","citation_count":19,"is_preprint":false},{"pmid":"33227407","id":"PMC_33227407","title":"PDIA1 acts as master organizer of NOX1/NOX4 balance and phenotype response in vascular smooth muscle.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33227407","citation_count":18,"is_preprint":false},{"pmid":"35226005","id":"PMC_35226005","title":"Adhesion properties of cell surface proteins in Lactobacillus strains in the GIT environment.","date":"2022","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/35226005","citation_count":18,"is_preprint":false},{"pmid":"33057122","id":"PMC_33057122","title":"Dsi-RNA knockdown of genes regulated by Foxo reduces glycogen and lipid accumulations in diapausing Culex pipiens.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33057122","citation_count":18,"is_preprint":false},{"pmid":"35006855","id":"PMC_35006855","title":"Injectable Cell- and Growth Factor-Free Poly(4-hydroxybutyrate) (P4HB) Microspheres with Open Porous Structures and Great Efficiency of Promoting Bone Regeneration.","date":"2021","source":"ACS applied bio materials","url":"https://pubmed.ncbi.nlm.nih.gov/35006855","citation_count":18,"is_preprint":false},{"pmid":"21437046","id":"PMC_21437046","title":"The impact of asthma on the gastrointestinal tract (GIT).","date":"2010","source":"Journal of asthma and allergy","url":"https://pubmed.ncbi.nlm.nih.gov/21437046","citation_count":18,"is_preprint":false},{"pmid":"29263160","id":"PMC_29263160","title":"P4HB recurrent missense mutation causing Cole-Carpenter syndrome.","date":"2017","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29263160","citation_count":17,"is_preprint":false},{"pmid":"26689230","id":"PMC_26689230","title":"Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 excludes Listeria monocytogenes from the GIT, as shown by bioluminescent studies in mice.","date":"2015","source":"Beneficial microbes","url":"https://pubmed.ncbi.nlm.nih.gov/26689230","citation_count":17,"is_preprint":false},{"pmid":"36463755","id":"PMC_36463755","title":"A discovery-based proteomics approach identifies protein disulphide isomerase (PDIA1) as a biomarker of β cell stress in type 1 diabetes.","date":"2022","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/36463755","citation_count":16,"is_preprint":false},{"pmid":"30948499","id":"PMC_30948499","title":"A novel missense mutation in P4HB causes mild osteogenesis imperfecta.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/30948499","citation_count":16,"is_preprint":false},{"pmid":"1647289","id":"PMC_1647289","title":"Regional assignment of the human gene coding for a multifunctional polypeptide (P4HB) acting as the beta-subunit of prolyl 4-hydroxylase and the enzyme protein disulfide isomerase to 17q25.","date":"1991","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1647289","citation_count":16,"is_preprint":false},{"pmid":"23676170","id":"PMC_23676170","title":"Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay.","date":"2013","source":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","url":"https://pubmed.ncbi.nlm.nih.gov/23676170","citation_count":16,"is_preprint":false},{"pmid":"34071205","id":"PMC_34071205","title":"Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34071205","citation_count":15,"is_preprint":false},{"pmid":"34103947","id":"PMC_34103947","title":"Role of Bacteria in the Incidence of Common GIT Cancers: The Dialectical Role of Integrated Bacterial DNA in Human Carcinogenesis.","date":"2021","source":"Infection and drug resistance","url":"https://pubmed.ncbi.nlm.nih.gov/34103947","citation_count":15,"is_preprint":false},{"pmid":"26364260","id":"PMC_26364260","title":"Assessing the contribution of the two protein disulfide isomerases PDIA1 and PDIA3 to cisplatin resistance.","date":"2015","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26364260","citation_count":14,"is_preprint":false},{"pmid":"38100120","id":"PMC_38100120","title":"ARID1A loss induces P4HB to activate fibroblasts to support lung cancer cell growth, invasion, and chemoresistance.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/38100120","citation_count":14,"is_preprint":false},{"pmid":"17881480","id":"PMC_17881480","title":"Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs.","date":"2007","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/17881480","citation_count":14,"is_preprint":false},{"pmid":"22807447","id":"PMC_22807447","title":"The adaptor protein and Arf GTPase-activating protein Cat-1/Git-1 is required for cellular transformation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22807447","citation_count":13,"is_preprint":false},{"pmid":"22895803","id":"PMC_22895803","title":"A validation study of the Nucleix DSI-Semen kit--a methylation-based assay for semen identification.","date":"2012","source":"International journal of legal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22895803","citation_count":13,"is_preprint":false},{"pmid":"2847359","id":"PMC_2847359","title":"Highly efficient procedure for production of human monoclonal antibodies: establishment of hybrids between Epstein-Barr virus-transformed B lymphocytes and heteromyeloma cells by use of GIT culture medium.","date":"1988","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2847359","citation_count":13,"is_preprint":false},{"pmid":"37880717","id":"PMC_37880717","title":"Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.","date":"2023","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/37880717","citation_count":12,"is_preprint":false},{"pmid":"19912111","id":"PMC_19912111","title":"The GIT-PIX complexes regulate the chemotactic response of rat basophilic leukaemia cells.","date":"2010","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19912111","citation_count":12,"is_preprint":false},{"pmid":"29384951","id":"PMC_29384951","title":"Cole-Carpenter syndrome-1 with a de novo heterozygous deletion in the P4HB gene in a Chinese girl: A case report.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29384951","citation_count":12,"is_preprint":false},{"pmid":"39251943","id":"PMC_39251943","title":"P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells.","date":"2024","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/39251943","citation_count":11,"is_preprint":false},{"pmid":"10678533","id":"PMC_10678533","title":"Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures.","date":"2000","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/10678533","citation_count":11,"is_preprint":false},{"pmid":"24917311","id":"PMC_24917311","title":"Isolation and screening of probiotic candidates from marron, Cherax cainii (Austin, 2002) gastrointestinal tract (GIT) and commercial probiotic products for the use in marron culture.","date":"2014","source":"Journal of fish diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24917311","citation_count":11,"is_preprint":false},{"pmid":"21978890","id":"PMC_21978890","title":"Engineering of living autologous human umbilical cord cell-based septal occluder membranes using composite PGA-P4HB matrices.","date":"2011","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/21978890","citation_count":11,"is_preprint":false},{"pmid":"23880452","id":"PMC_23880452","title":"Two thioredoxin-superfamily members from sea bass (Dicentrarchus labrax, L.): characterization of PDI (PDIA1) and ERp57 (PDIA3).","date":"2013","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23880452","citation_count":10,"is_preprint":false},{"pmid":"36418900","id":"PMC_36418900","title":"Construction of a synthetic methodology-based library and its application in identifying a GIT/PIX protein-protein interaction inhibitor.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36418900","citation_count":10,"is_preprint":false},{"pmid":"19446546","id":"PMC_19446546","title":"The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.","date":"2009","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19446546","citation_count":10,"is_preprint":false},{"pmid":"23349913","id":"PMC_23349913","title":"Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23349913","citation_count":9,"is_preprint":false},{"pmid":"37205565","id":"PMC_37205565","title":"The endoplasmic reticulum stress sensor IRE1 regulates collagen secretion through the enforcement of the proteostasis factor P4HB/PDIA1 contributing to liver damage and fibrosis.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37205565","citation_count":9,"is_preprint":false},{"pmid":"38211723","id":"PMC_38211723","title":"Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.","date":"2024","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38211723","citation_count":9,"is_preprint":false},{"pmid":"31116733","id":"PMC_31116733","title":"The dPix-Git complex is essential to coordinate epithelial morphogenesis and regulate myosin during Drosophila egg chamber development.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31116733","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52760,"output_tokens":5217,"usd":0.118267,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13655,"output_tokens":5010,"usd":0.096763,"stage2_stop_reason":"end_turn"},"total_usd":0.21503,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"A heterozygous missense mutation in P4HB (p.Tyr393Cys) located in the C-terminal disulfide isomerase domain of PDI sterically close to the enzymatic center impairs disulfide isomerase activity in vitro and causes Cole-Carpenter syndrome, a severe bone fragility disorder. Skin fibroblasts showed increased ER stress, but collagen type I secretion rate appeared normal.\",\n      \"method\": \"Whole-exome sequencing, in vitro disulfide isomerase activity assay, ER stress analysis in patient skin fibroblasts\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 / Strong — in vitro enzymatic assay directly demonstrating loss of disulfide isomerase activity, combined with patient cell functional studies and identification of causative mutation; replicated in subsequent papers\",\n      \"pmids\": [\"25683117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PDIA1/P4HB is required for efficient proinsulin disulfide maturation in pancreatic β cells. β cell-specific Pdia1 deletion in mice exacerbated glucose intolerance, increased the proinsulin/insulin ratio, caused accumulation of disulfide-linked high-molecular-weight proinsulin complexes, and produced ER vesiculation, mitochondrial swelling, and nuclear condensation.\",\n      \"method\": \"Conditional β cell-specific Pdia1 knockout mice, glucose tolerance tests, proinsulin/insulin ratio measurement in serum and islets, ultrastructural analysis, oxidative stress assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with multiple orthogonal phenotypic readouts (biochemical, ultrastructural, metabolic) in vivo\",\n      \"pmids\": [\"31184304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PDIA1 plays indispensable roles in APOB folding and MTTP synthesis/function to support VLDL assembly and secretion in hepatocytes. Hepatocyte-specific Pdia1 deletion inhibited MTTP expression at the translational level (not mRNA or protein stability), dramatically reduced VLDL production, and caused severe hepatic steatosis and hypolipidemia. PDIA1 interacts with APOB in an MTTP-independent manner via its chaperone function. Catalytically inactivated PDIA1 mutant failed to rescue these phenotypes.\",\n      \"method\": \"Conditional hepatocyte-specific Pdia1 knockout mice, lipoprotein secretion assays, mRNA/protein stability analysis, Co-IP between PDIA1 and APOB, catalytic mutant complementation\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo conditional knockout with mechanistic dissection using catalytic mutants and direct protein interaction assays\",\n      \"pmids\": [\"38211723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"P4HB is a substrate for UFMylation at three lysine residues (mono-UFMylation). UFMylation deficiency promotes P4HB protein degradation via the ubiquitin-proteasome pathway, leading to mitochondrial function damage, oxidative stress, and ER stress in HepG2 cells.\",\n      \"method\": \"Stable cell line with UFMylation-defective P4HB, proteasome inhibitor rescue experiments, mitochondrial function assays, ROS measurement, ER stress markers\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — identification of a novel PTM with functional consequence demonstrated in a cell line, single lab with multiple assays\",\n      \"pmids\": [\"35753586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"P4HB is lactylated at lysine K311; aloe emodin inhibits binding of lactate to the K311 site of P4HB. P4HB lactylation was identified as a novel post-translational modification relevant to radiation-induced heart disease.\",\n      \"method\": \"4D label-free lactylation omics, cross differential omics, molecular docking, identification of K311 as the lactylation site\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — proteomics-based PTM identification with site-specific mapping, single lab\",\n      \"pmids\": [\"39494721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"P4HB inhibition (by RNAi knockdown or bacitracin) sensitizes temozolomide-resistant glioblastoma cells to TMZ through the PERK arm of the endoplasmic reticulum stress response. P4HB overexpression conferred TMZ resistance in sensitive cells.\",\n      \"method\": \"RNAi knockdown, pharmacological inhibition (bacitracin), in vitro and in vivo xenograft models, ER stress pathway analysis (PERK arm)\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function with defined pathway placement (PERK-ER stress), validated in vivo, single lab\",\n      \"pmids\": [\"23444257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"P4HB encodes a multifunctional polypeptide that serves as the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer (which catalyzes 4-hydroxyproline formation in collagens) and is identical to the enzyme protein disulfide isomerase. The gene was mapped to chromosome 17q25.\",\n      \"method\": \"In situ hybridization, Southern blot analysis of chromosome-mediated gene transfer transfectant panel\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — dual functional identity established biochemically and replicated across multiple subsequent studies; chromosomal mapping confirmed\",\n      \"pmids\": [\"1647289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"P4HB (PDI) in its tetrameric form catalyzes hydroxylation of proline residues within X-Pro-Gly repeats in the procollagen helical domain. The recurrent mutation p.Tyr393Cys in the C-terminal reactive centre interferes with disulfide isomerase function of PDI. Fibroblast analysis suggests P4HB perturbation disrupts ECM organization and assembly rather than collagen type I secretion per se.\",\n      \"method\": \"Collagen analysis in cultured fibroblasts, electron microscopy, exome sequencing, clinical phenotyping\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fibroblast functional assays with structural analysis, single lab, confirms prior finding\",\n      \"pmids\": [\"29263160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PDIA1 acts as master organizer of NOX1/NOX4 balance in vascular smooth muscle cells (VSMCs). Early PDIA1 overexpression increased NOX1 expression, H2O2 levels, and spontaneous VSMC migration; sustained overexpression also increased NOX4 and switched VSMC phenotype to differentiation. PDIA1 knockdown decreased nuclear myocardin and increased PCNA expression. Both NOX1 and H2O2 were necessary for PDIA1-induced VSMC differentiation. In vivo, TgPDIA1 carotids showed decreased NOX1 and enhanced NOX4/calponin, indicating overdifferentiation.\",\n      \"method\": \"Inducible PDIA1 overexpression in VSMCs, siRNA knockdown, transgenic PDIA1-overexpressing mice (TgPDIA1), rabbit overdistension injury model, NOX1/NOX4 expression and activity assays, nuclear myocardin imaging\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (overexpression, knockdown, transgenic mice, in vivo injury model) from single lab with multiple functional readouts\",\n      \"pmids\": [\"33227407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PDIA1 (P4HB) is a target protein of Disulfide bond Disrupting Agents (DDAs). Affinity purification with biotinylated DDAs identified PDIA1 as a DDA-binding protein. DDA treatment of breast cancer cells disrupts PDIA1 mixed disulfide bonds with client proteins, contributing to DR4/DR5 oligomerization and cancer cell death.\",\n      \"method\": \"Affinity purification with biotinylated-DDAs, shRNA knockdown, mixed disulfide bond analysis\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — affinity purification identifies direct binding, functional consequence demonstrated, single lab\",\n      \"pmids\": [\"35247515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"P4HB is secreted in extracellular vesicles from esophageal squamous cell carcinoma cells and promotes apoptosis of skeletal muscle cells by activating the ubiquitin-dependent proteolytic pathway and regulating the stability of PHGDH and subsequent antiapoptotic protein Bcl-2, contributing to cancer cachexia.\",\n      \"method\": \"ESCC-induced cachexia mouse model, EV isolation, P4HB inhibitor (CCF642) treatment, apoptosis assays, PHGDH/Bcl-2/caspase-3 pathway analysis\",\n      \"journal\": \"Journal of extracellular vesicles\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo functional studies with defined pathway (PHGDH/Bcl-2/caspase-3), single lab\",\n      \"pmids\": [\"33732415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SAL (salidroside) inhibits skin inflammation and melanogenesis by targeting P4HB (confirmed by molecular docking and Biacore binding). P4HB mediates ubiquitination-dependent degradation of IRF1; inhibition of P4HB by SAL prevents IRF1 ubiquitin degradation. IRF1 and USF1 form a transcription complex that regulates tyrosinase (TYR) mRNA expression.\",\n      \"method\": \"Molecular docking, Biacore surface plasmon resonance, Co-IP, pull-down, proximity ligation assay, luciferase reporter assay, immunofluorescence, Western blot\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding confirmed by SPR, protein interaction validated by Co-IP/pull-down, mechanistic pathway established, single lab\",\n      \"pmids\": [\"33042273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The ER stress sensor IRE1 regulates collagen secretion through transcriptional induction of P4HB/PDIA1, which is required for collagen maturation. Genetic ablation of IRE1 reduced P4HB expression, caused collagen retention at the ER and altered secretion, and diminished collagen deposition in liver fibrosis models. P4HB overexpression rescued collagen secretion in IRE1-deficient cells.\",\n      \"method\": \"IRE1 genetic ablation, carbon tetrachloride and high-fat diet liver fibrosis models, proteomic and transcriptomic profiling, P4HB overexpression rescue, collagen retention/secretion assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic ablation with rescue experiment, multiple in vivo models, preprint not yet peer-reviewed\",\n      \"pmids\": [\"37205565\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"P4HB promotes malignant glioma phenotypes (proliferation, invasion, migration, angiogenesis) via the MAPK signaling pathway. Genetic and pharmacologic inhibition of P4HB suppressed MAPK expression and downstream angiogenic/invasive targets.\",\n      \"method\": \"P4HB overexpression and knockdown, in vitro proliferation/invasion/migration/angiogenesis assays, in vivo tumor growth, MAPK pathway analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function with defined pathway placement (MAPK), validated in vivo, single lab\",\n      \"pmids\": [\"29069756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"P4HB interacts with PRMT1 (confirmed by immunoprecipitation), and this interaction mediates P4HB's regulation of the TGFβ/SMAD3 signaling pathway in high glucose-induced renal tubular epithelial cells. Silencing P4HB inhibited EMT and fibrosis; overexpression of PRMT1 reversed P4HB knockdown effects on EMT, fibrosis, and TGFβ/SMAD3 signaling.\",\n      \"method\": \"siRNA knockdown, overexpression vectors, immunoprecipitation (P4HB-PRMT1 interaction), Western blot, immunofluorescence, ROS assay\",\n      \"journal\": \"BMC nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP identifies interaction, epistasis by overexpression rescue supports pathway placement, single lab\",\n      \"pmids\": [\"39251943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"COL10A1 directly interacts with P4HB (confirmed by Co-IP). P4HB is required for COL10A1-mediated promotion of breast cancer cell proliferation, migration, and invasion, as P4HB knockdown abrogated the promoting effects of COL10A1 overexpression.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of P4HB, CCK-8 proliferation assay, wound healing and transwell migration/invasion assays\",\n      \"journal\": \"Medical science monitor\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP with functional rescue, single lab, no deeper mechanistic characterization\",\n      \"pmids\": [\"33637669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition (EMT). GRP78 overexpression antagonized the oncogenic effects of P4HB overexpression in HCC cells.\",\n      \"method\": \"P4HB overexpression and silencing, in vitro growth/migration/invasion/EMT assays, in vivo tumor xenografts, GRP78 modulation\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss-of-function with pathway placement (GRP78/EMT), in vivo validation, single lab\",\n      \"pmids\": [\"28052026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P4HB knockdown in HT29 colon cancer cells induces apoptosis through accumulation of reactive oxygen species (ROS) and subsequent inactivation of STAT3 signaling. Inhibiting ROS accumulation abrogated the increased apoptosis, and decreased ROS effectively antagonized P4HB knockdown effects on STAT3 inactivation.\",\n      \"method\": \"siRNA knockdown, ROS measurement, STAT3 phosphorylation assay, apoptosis assay, ROS inhibitor rescue\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via chemical rescue establishes ROS→STAT3 as mechanistic pathway downstream of P4HB, single lab\",\n      \"pmids\": [\"30431122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARID1A depletion in lung cancer cells augments P4HB expression and secretion; secreted P4HB induces activation of lung fibroblasts through the β-catenin signaling pathway. P4HB-activated fibroblasts promote proliferation, invasion, and chemoresistance of lung cancer cells. Antibody-based P4HB neutralization hampered tumor growth and increased cisplatin efficacy in PDX models.\",\n      \"method\": \"siRNA knockdown of ARID1A, conditioned media experiments, antibody neutralization, β-catenin pathway analysis, PDX mouse models\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (β-catenin) established with in vivo PDX validation and neutralization rescue, single lab\",\n      \"pmids\": [\"38100120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PDIA1 is upregulated in NOD mouse islets and pancreatic sections from humans with autoantibody positivity or T1D. PDIA1 plasma levels are increased in pre-diabetic NOD mice and in children with recent-onset T1D, suggesting PDIA1 as a biomarker of β cell stress.\",\n      \"method\": \"Data independent acquisition-mass spectrometry on longitudinally collected islets from NOD mice, immunohistochemistry of human pancreatic sections, ELISA for plasma PDIA1\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proteomics/IHC-based correlation without direct mechanistic experiment on P4HB function; primarily biomarker identification\",\n      \"pmids\": [\"36463755\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P4HB/PDIA1 encodes the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer and is identical to protein disulfide isomerase (PDI); it resides in the ER where it catalyzes disulfide bond formation and isomerization essential for folding of collagen (via the prolyl 4-hydroxylase complex), proinsulin, apolipoprotein B (APOB), and MTTP, thereby controlling VLDL secretion and insulin production; it is subject to UFMylation (stabilizing it) and lactylation (at K311), and its activity is regulated by the ER stress sensor IRE1 which drives P4HB transcription to support collagen secretion; loss-of-function mutations (e.g., p.Tyr393Cys) impair disulfide isomerase activity and cause Cole-Carpenter syndrome/osteogenesis imperfecta; in vascular smooth muscle, PDIA1 orchestrates the NOX1/NOX4 balance to control phenotype switching; in cancer contexts, P4HB promotes malignant phenotypes via MAPK signaling, STAT3/ROS pathways, and by regulating fibroblast activation through β-catenin, and its inhibition restores chemosensitivity through the PERK/ER stress pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"P4HB encodes a multifunctional ER-resident polypeptide that is simultaneously the beta-subunit of the prolyl 4-hydroxylase alpha2beta2 tetramer and the enzyme protein disulfide isomerase (PDI/PDIA1), thereby coupling collagen prolyl hydroxylation with oxidative protein folding [#6]. Through its disulfide isomerase activity it governs the maturation of multiple secretory clients: it is required for proinsulin disulfide maturation in pancreatic beta cells, where its loss elevates the proinsulin/insulin ratio and produces disulfide-linked high-molecular-weight proinsulin aggregates [#1], and it supports hepatic VLDL assembly by chaperoning APOB and enabling MTTP synthesis, with catalytic activity being essential for these functions [#2]. Its expression is wired to the unfolded protein response: the ER stress sensor IRE1 transcriptionally induces P4HB to drive collagen maturation and secretion [#12]. A heterozygous p.Tyr393Cys mutation in the C-terminal disulfide isomerase domain abolishes isomerase activity and causes Cole-Carpenter syndrome, a severe bone fragility/osteogenesis imperfecta disorder, acting through disrupted ECM organization rather than a defect in collagen type I secretion per se [#0, #7]. P4HB protein abundance and activity are tuned by post-translational modification, including stabilizing UFMylation whose loss triggers proteasomal degradation, oxidative and ER stress [#3]. Beyond folding, P4HB orchestrates redox signaling—balancing NOX1/NOX4 to control vascular smooth muscle phenotype switching [#8]—and in cancer it promotes malignant phenotypes through MAPK signaling [#13], ROS/STAT3 signaling [#17], GRP78 downregulation with EMT [#16], and secreted P4HB that activates fibroblasts via beta-catenin to drive chemoresistance [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established the dual molecular identity of P4HB, showing one gene product serves both as the prolyl 4-hydroxylase beta-subunit and as protein disulfide isomerase, defining its place in collagen biosynthesis and oxidative folding.\",\n      \"evidence\": \"In situ hybridization and Southern blot of chromosome-transfer transfectants mapping the gene and establishing dual function\",\n      \"pmids\": [\"1647289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how the two catalytic roles are partitioned in vivo\", \"No structural model of the alpha2beta2 tetramer provided\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked P4HB activity to chemoresistance, showing its inhibition sensitizes resistant tumor cells via the PERK arm of the ER stress response.\",\n      \"evidence\": \"RNAi and bacitracin inhibition with PERK pathway analysis in temozolomide-resistant glioblastoma, validated in xenografts\",\n      \"pmids\": [\"23444257\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Bacitracin is not P4HB-specific\", \"Direct catalytic dependence not dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that a specific P4HB mutation causes human disease by impairing disulfide isomerase activity, tying enzymatic loss-of-function to a Mendelian bone fragility syndrome.\",\n      \"evidence\": \"Whole-exome sequencing, in vitro isomerase assay, and ER stress analysis of patient fibroblasts for p.Tyr393Cys\",\n      \"pmids\": [\"25683117\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Normal collagen I secretion left the bone phenotype mechanism unresolved\", \"Heterozygous mechanism (dominant-negative vs haploinsufficiency) not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Refined the disease mechanism, indicating P4HB perturbation disrupts ECM organization and assembly rather than collagen type I secretion itself.\",\n      \"evidence\": \"Collagen and electron microscopy analysis of patient fibroblasts with exome sequencing\",\n      \"pmids\": [\"29263160\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of ECM disorganization not identified\", \"Single-lab fibroblast study\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Placed P4HB's oncogenic activity downstream of defined signaling, implicating MAPK and GRP78/EMT axes in tumor promotion.\",\n      \"evidence\": \"Gain/loss-of-function with MAPK pathway analysis in glioma and GRP78 modulation in HCC, both with in vivo validation\",\n      \"pmids\": [\"29069756\", \"28052026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How catalytic isomerase function connects to MAPK/GRP78 not established\", \"Direct substrates in these pathways unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a ROS-STAT3 axis downstream of P4HB, showing its knockdown drives apoptosis through ROS accumulation and STAT3 inactivation.\",\n      \"evidence\": \"siRNA knockdown with ROS measurement, STAT3 phosphorylation, and ROS-inhibitor rescue in colon cancer cells\",\n      \"pmids\": [\"30431122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Source of ROS upon P4HB loss not identified\", \"Single-lab in vitro study\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a physiological catalytic role in proinsulin folding, showing P4HB is required for proinsulin disulfide maturation and beta cell function.\",\n      \"evidence\": \"Beta cell-specific Pdia1 knockout mice with glucose tolerance, proinsulin/insulin ratio, and ultrastructural analysis\",\n      \"pmids\": [\"31184304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PDIA1 acts directly on proinsulin disulfides or via partner chaperones not resolved\", \"Specific disulfide bonds catalyzed not mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a redox-signaling role beyond folding, with PDIA1 acting as master organizer of the NOX1/NOX4 balance to control vascular smooth muscle phenotype switching.\",\n      \"evidence\": \"Inducible overexpression, siRNA, transgenic mice, and in vivo injury model with NOX activity and myocardin readouts\",\n      \"pmids\": [\"33227407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which PDIA1 sets NOX1/NOX4 balance not defined\", \"Direct interaction with NOX enzymes not shown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified P4HB as a regulator of IRF1 stability, controlling melanogenesis and skin inflammation through ubiquitin-dependent degradation of IRF1.\",\n      \"evidence\": \"SPR binding, Co-IP, pull-down, PLA, and luciferase assays with the inhibitor salidroside\",\n      \"pmids\": [\"33042273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How P4HB mechanistically promotes IRF1 ubiquitination unclear\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended P4HB function to extracellular and cancer-cachexia contexts, showing secreted/EV P4HB and direct partners drive muscle apoptosis and tumor aggression.\",\n      \"evidence\": \"EV isolation with PHGDH/Bcl-2 pathway analysis in ESCC cachexia, Co-IP with COL10A1 in breast cancer, and biomarker proteomics in T1D islets\",\n      \"pmids\": [\"33732415\", \"33637669\", \"36463755\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How an ER-resident protein is secreted and functions extracellularly not mechanistically resolved\", \"COL10A1 interaction rests on a single Co-IP with functional rescue\", \"T1D data are correlative biomarker findings without direct mechanism\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed P4HB stability is post-translationally controlled by UFMylation, linking this modification to redox and ER homeostasis.\",\n      \"evidence\": \"UFMylation-defective P4HB cell line with proteasome rescue, mitochondrial, ROS, and ER stress assays in HepG2\",\n      \"pmids\": [\"35753586\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"UFMylated lysine residues not individually mapped to function\", \"Ligase/machinery directing P4HB UFMylation not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified P4HB as the molecular target of disulfide-bond-disrupting agents, connecting its mixed-disulfide client interactions to death-receptor oligomerization in cancer.\",\n      \"evidence\": \"Affinity purification with biotinylated DDAs, shRNA knockdown, and mixed disulfide bond analysis in breast cancer cells\",\n      \"pmids\": [\"35247515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full client repertoire forming mixed disulfides not enumerated\", \"Single-lab characterization\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Wired P4HB expression to the unfolded protein response, showing IRE1 transcriptionally induces P4HB to enable collagen maturation and secretion.\",\n      \"evidence\": \"IRE1 genetic ablation with P4HB overexpression rescue in liver fibrosis models (preprint)\",\n      \"pmids\": [\"37205565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Transcription factor link between IRE1 and the P4HB promoter not detailed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined P4HB as a secreted driver of stromal activation, showing ARID1A loss elevates secreted P4HB that activates fibroblasts via beta-catenin to promote chemoresistance.\",\n      \"evidence\": \"ARID1A knockdown, conditioned media, antibody neutralization, and PDX models in lung cancer\",\n      \"pmids\": [\"38100120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Fibroblast receptor for secreted P4HB not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established an essential catalytic role in hepatic lipoprotein metabolism, with P4HB chaperoning APOB and enabling MTTP synthesis to support VLDL secretion.\",\n      \"evidence\": \"Hepatocyte-specific Pdia1 knockout, Co-IP with APOB, translational analysis of MTTP, and catalytic-mutant complementation\",\n      \"pmids\": [\"38211723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which P4HB controls MTTP translation specifically unresolved\", \"Chaperone vs catalytic contributions to APOB binding not fully separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Added new layers of post-translational and interaction-based regulation, identifying K311 lactylation and a PRMT1 interaction modulating TGFbeta/SMAD3-driven fibrosis.\",\n      \"evidence\": \"4D lactylation proteomics and docking for K311; Co-IP and overexpression epistasis for PRMT1 in renal tubular cells\",\n      \"pmids\": [\"39494721\", \"39251943\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of K311 lactylation on enzymatic activity not measured\", \"PRMT1 interaction rests on single-lab Co-IP and rescue\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single ER-resident isomerase coordinates its catalytic folding functions with its diverse cytosolic, extracellular, and signaling roles, and how its many post-translational modifications integrate to regulate these activities, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural/mechanistic model linking folding catalysis to signaling outputs\", \"Secretion route for an ER-resident protein unexplained\", \"Substrate-level specificity across tissues not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [0, 1, 2, 6, 7]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 2, 12]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [10, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 2, 6, 12]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 12]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [6, 7, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 13, 17, 18]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\"prolyl 4-hydroxylase alpha2beta2 tetramer\"],\n    \"partners\": [\"APOB\", \"MTTP\", \"PRMT1\", \"COL10A1\", \"IRF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}